MSP Recovery ROE 2020-2024 | LIFW

Current and historical return on equity (ROE) values for MSP Recovery (LIFW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
MSP Recovery ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $-0.07B $1.24B -4.58%
2023-12-31 $-0.06B $1.42B -3.26%
2023-09-30 $-0.02B $1.64B -1.20%
2023-06-30 $-0.01B $1.80B -0.18%
2023-03-31 $0.00B $2.01B 0.03%
2022-12-31 $-0.01B $2.19B -0.25%
2022-09-30 $-0.04B $5.39B -1.43%
2022-06-30 $-0.05B $5.42B -3.52%
2022-03-31 $-0.05B $-0.02B 109.09%
2021-12-31 $-0.03B $-0.15B 79.01%
2021-06-30 $-0.00B $0.01B 133.33%
2021-03-31 $0.01B $0.01B -181.82%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.257B 19.36
Tempus AI (TEM) United States $5.669B 0.00
Hims & Hers Health (HIMS) United States $4.401B 0.00
Inspire Medical Systems (INSP) United States $3.980B 0.00
Axonics (AXNX) United States $3.445B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.202B 0.00
IRhythm Technologies (IRTC) United States $3.010B 0.00
Azenta (AZTA) United States $2.800B 157.42
Enovis (ENOV) United States $2.438B 18.07
10x Genomics (TXG) United States $2.234B 0.00
Privia Health (PRVA) United States $2.022B 113.00
Schrodinger (SDGR) United States $1.461B 0.00
Omnicell (OMCL) United States $1.229B 42.48
Phreesia (PHR) United States $1.177B 0.00
Standard BioTools (LAB) United States $0.682B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Clover Health Investments (CLOV) United States $0.621B 0.00
Fulgent Genetics (FLGT) United States $0.596B 0.00
Health Catalyst (HCAT) United States $0.365B 0.00
Talkspace (TALK) United States $0.365B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.305B 0.00
Pulmonx (LUNG) United States $0.245B 0.00
Butterfly Network (BFLY) United States $0.209B 0.00
Outset Medical (OM) United States $0.199B 0.00
TruBridge (TBRG) United States $0.168B 9.02
P3 Health Partners (PIII) United States $0.157B 0.00
American Well (AMWL) United States $0.089B 0.00
111 (YI) China $0.088B 0.00
EUDA Health Holdings (EUDA) Singapore $0.080B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
HeartBeam (BEAT) United States $0.071B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
Augmedix (AUGX) United States $0.049B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.048B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
CareCloud (CCLD) United States $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.031B 0.00
Movano (MOVE) United States $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Biotricity (BTCY) United States $0.007B 0.00
Transgenomic (PRPO) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00